References
Leblond C.P., Carriere R. The effect of growth hormone and thyroxine on the mitotic rate of the intestinal mucosa of the rat. Endocrinology 56: 261, 1955.
Short J., Wedmore R., Kibert L., Zemel R. Triiodothyronine: on its role as a specific hepatomitogen. Cytobios 28: 165, 1980.
Kumegawa M., Ikeda E., Hosoda S., Takuma T. In vitro effects of thyroxine and insulin on myoblasts from chick embryo skeletal muscle. Dev. Biol. 79: 493, 1980.
Lauder J.M. The effects of early hypo- and hyperthyroidism on the development of rat cerebellar cortex. III. Kinetics of cell proliferation in the external granular layer. Brain Res. 126: 31, 1977.
Patel A.J., Lewis P.D., Balazs R., Bailey P., Lai M. Effects of thyroxine on postnatal cell acquisition in the rat brain. Brain Res. 172: 57, 1979.
Nunez J. Effects of thyroid hormone during brain differentiation. Mol. Cell. Endocrinol. 37: 125, 1984.
Hayashi I., SatoG. H. Replacement of serum by hormones permits growth of cells in a defined medium. Nature 259: 132, 1976.
Aizenman Y., De Vellis J. Brain neurons develop in a serum and glial-free environment: effects of transferrin, insulin, insulin like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation. Brain Res. 406: 32, 1987.
Miller M.J., Fels E.C., Shapiro L.E., Surks M.I. L-triiodothyronine stimulates growth by means of an autocrine factor in a cultured growth hormone-producing cell line. J.Clin. Invest. 79: 1773, 1987.
Surks M.I., DeFesi C.R. Determination of the absolute cell number of each cell type in the anterior pituitary of euthyroid and hypothyroid rats. Endocrinology 101: 946, 1977.
Astier H.S., DeFesi C.R., Surks M.I. Kinetics of deoxyribonucleic acid synthesis and replication of thyrotrophs and somatotrophs during development of hypothyroidism and L-triiodothyronine treatment of hypothyroid rats. Endocrinology 106: 1537, 1980.
DeFesi C.R., Astier H.S., Surks M.I. Kinetics of thyrotrophs and somatotrophs during development of hypothyroidism and L-triiodothyronine treatment of hypothyroid rats. Endocrinology 104: 1172, 1979.
DeFesi C.R., Fels E.C., Surks M.I. T3 stimulates growth of cultured GC cells by action early in the G1 period. Endocrinology 114:293, 1983.
DeFesi C.R., Fels E.C., Surks M.I. L-triiodothyronine (T3) stimulates growth of cultured GC cells by action early in the G1 period. Evidence for mediation by the nuclear T3 receptor. Endocrinology 116: 2062, 1985.
Samuels H.H., Shapiro L.E. Thyroid hormone stimulates de novo growth hormone synthesis in cultured GH1 cells: evidence for the accumulation of a rate-limiting RNA species in the induction process. Proc. Natl. Acad. Sci. USA 73: 3369, 1976.
Samuels H.H., Stanley F., Shapiro L.E. Dose-dependent depletion of nuclear receptors by L-triiodothyronine: evidence for a role in induction of growth hormone synthesis in cultured GH1 cells. Proc. Natl. Acad. Sci. USA 73: 3877, 1976.
Samuels H.H., Horwitz Z.D., Stanley F., Casanova J., Shapiro L.E. Thyroid hormone controls glucocorticoid action in cultured GH1 cells. Nature 268: 254, 1977.
Seo H., Vassart G., Brocas H., Refetoff S. Triiodothyronine stimulates specifically growth hormone mRNA in rat pituitary tumor cells. Proc. Natl. Acad. Sci. USA 74: 2054, 1977.
Shapiro L.E., Samuels H.H., Yaffe B.M. Thyroid and glucocorticoid hormones synergistically control growth hormone mRNA in cultured GH1 cells. Proc. Natl. Acad. Sci. USA 75: 45, 1978.
Spindler S.R., Mellon S.H., Baxter J.D. Growth hormone gene transcription is regulated by thyroid and glucocorticoid hormones in cultured rat pituitary tumor cells. J. Biol. Chem. 257: 11627, 1982.
Yaffe B.M., Samuels H. Hormonal regulation of the growth hormone gene. Relationship of the rate of transcription to the level of nuclear thyroid hormone-receptor complexes. J. Biol. Chem. 259: 6284, 1984.
Diamond D.J., Goodman H.M. Regulation of growth hormone messenger RNA synthesis by dexamethasone and triiodothyronine. J.Mol. Biol. 181: 41, 1985.
Dobner P.R., Kawasaki E.S., Yu L., Bancroft F.C. Thyroid or glucocorticoid hormone induces pregrowth hormone mRNA and its probable nuclear precursor in rat pituitary cells. Proc. Natl. Acad. Sci. USA 78: 2230, 1981.
Silverman B.L., Kaplan S.L., Grumbach M.M., Miller W.L. Hormonal regulation of growth hormone secretion and messenger ribonucleic acid accumulation in cultured bovine pituitary cells. Endocrinology 122: 1236, 1988.
Mulchahey J.J., Di Blasio A.M., Jaffe R.B. Effects of growth hormone (GH)-releasing hormone and somatostatin on GH secretion from individual human and monkey fetal anterior pituitary cells: modulation by thyroid hormones and glucocorticoids. J. Clin. Endocrinol. Metab. 66: 395, 1988.
Adams E.F., Brajkovich I.E., Mashiter K. Growth hormone and prolactin secretion by dispersed cell cultures of human pituitary adenomas: long term effects of hydrocortisone, estradiol, insulin, 3, 5, 3′-triiodothyronine and thyroxine. J. Clin. Endocrinol. Metab. 53: 381, 1981.
Cattini P.A., Anderson T.R., Baxter J.C., Mellon P. Eberhardt N.L. The human growth hormone gene is negatively regulated by triiodothyronine when transfected into rat pituitary tumor cells. J. Biol. Chem. 261: 13367, 1986.
Brent G.A., Harney J.W., Moore D.D., Larsen P.R. Multihormonal regulation of the human, rat, and bovine growth hormone promoters: differential effects of 3′,5′-cyclic adenosine monophosphate, thyroid hormone, and glucocorticoids. Mol. Endocrinol. 2: 792, 1988.
Peake G.T., Birge C.A., Daughaday W.H. Alterations of radioimmunoassayable growth hormone and prolactin during hypothyroidism. Endocrinology 92: 487, 1973.
Hervas F., Morreale de Escobar G., Escobar Del Rey F. Rapid effects of single small doses of L-thyroxine and triiodo-L-thyronine on growth hormone, as studied in the rat by radioimmunoassay. Endocrinology 97: 91, 1975.
Mosier H.D., Dearden L.C., Jansons R.A., Hill R.R. Growth hormone, somatomedin and cartilage sulfation in failure of catch-up growth after propylth-iouracyl-induced hypothyroidism in the rat. Endocrinology 100: 1644, 1977.
Coiro V., Braverman L.E., Christianson D., Fang S-L., Goodman H.M. Effect of hypothyroidism and thyroxine replacement on growth hormone in the rat. Endocrinology 795: 641, 1979.
Coulombe P., Schwartz H.L., Oppenheimer J.H. Relationship between the accumulation of pituitary growth hormone and nuclear occupancy by triiodothyronine in the rat. J.Clin. Invest. 62: 1020, 1978.
Hinkle P.M., Goh K.B.C. Regulation of thyrotropin-releasing hormone receptors and responses by L-triiodothyronine in dispersed rat pituitary cell cultures. Endocrinology 110: 1725, 1982.
Martin D., Epelbaum J., Bluet-Pajot M-T., Prelot M., Kordon C., Durand D. Thyroidectomy abolishes pulsatile growth hormone secretion without affecting hypothalamic somatostatin. Neuroendocrinology 47: 476, 1985.
Katakami H., Downs T.R., Frohman L.A. Decreased hypothalamic growth hormone-releasing hormone content and pituitary responsiveness in hypothyroidism. J.Clin. Invest. 77: 1704, 1986.
Root J.L., Duckett G.E., Sweetland M., Strzelecki J.A., Root A.W. Hypothyroidism blunts the growth hormone (GH) releasing effect of human pancreatic GH releasing factor in the adult male rat in vivo and in vitro. Endocrinology 116: 1703, 1985.
Dieguez C., Jordan V., Harris P., Foord S.M., Rodriguez-Arnao M.D., Gomez-Pan A., Hall R., Scanlon M.F. Growth hormone responses to growth hormone releasing factor (12-29) in euthyroid, hypothyroid and hyperthyroid rats. J. Endocrinol. 709: 53, 1986.
Edwards C.A., Dieguez C., Scanlon M.F. Effects of hypothyroidism, tri-iodothyronine and glucocorticoids on growth hormone responses to growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2. J. Endocrinol. 727: 31, 1989.
Root A.W., Shulman D., Root J., Diamond F. The interrelationships of thyroid and growth hormone: effect of growth hormone releasing hormone in hypo- and hyperthyroid male rats. Acta. Endocrinol, suppl. 229: 367, 1986.
Walker P., Weichsel M.E. Jr., Fisher D.A., Guo S.M., Fisher D.A. Thyroxine increases nerve growth factor concentration in adult mouse brain. Science 204: 427, 1979.
Walker P., Weil M.L., Weichsel M.E. Jr., Fisher D.A. Effect of thyroxine on nerve growth factor concentration in neonatal mouse brain. Life Sci. 28: 1777, 1981.
Salido E.C., Lakshmanan J., Koy S., Barajas L., Fisher D.A. Effect of thyroxine administration on the expression of epidermal growth factor in the kidney and submandibular gland of neonatal mice. An immunocy-tochemical and in situ hybridization study. Endocrinology 727: 2263, 1990.
Dainiak N., Sutter D., Kreczko S. L-triiodothyronine augments erythropoietic growth factor release from peripheral blood and bone marrow leukocytes. Blood 68: 1289, 1986.
Salmon W.D., Daughaday W.H. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J. Lab. & Clin. Med. 49: 825, 1957.
van Wyk J.J. The somatomedins: biological actions and physiologic control mechanisms. In: Li CH (ed). Horm. Prot. Pet. Vol 12. Academic Press, New York, p. 82, 1984.
Scheiwiller E., Guler H-P., Merryweather J., Scandella C., Maerki W., Zapf J., Froesch E.R. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 323: 169, 1986.
Smith A.T., Clemmons D.R., Underwood L.E., BenEzra U., McMurray R. The effect of exercise on plasma somatomedin-C/lnsulin-like growth factor concentrations. Metabolism 36: 533, 1987.
Burch W.M., van Wyk J.J. Triiodothyronine stimulates cartilage growth and maturation by different mechanisms. Am. J. Physiol. 252: E176, 1987.
Gaspard T., Wondergem R., Hamamdzic M., Klitgaard H.M. Serum somatomedin stimulation in thyroxine-treated hypophysectomized rats. Endocrinology 702: 606, 1978.
Chernausek S.D., Underwood L.E., van Wyk J.J. Influence of hypothyroidism on growth hormone binding by rat liver. Endocrinology 111: 1534, 1982.
Burstein P.J., Draznin B., Johnson C.J., Schalch D.S. The effect of hypothyroidism on growth, serum growth hormone, the growth hormone-dependent somatomedin, insulin-like growth factor, and its carrier protein in rats. Endocrinology 704: 1107, 1979.
Bergenstal D.M., Lippset M.B. Metabolic effects of human growth hormone and growth hormone of other species in man. J. Clin. Endocrinol. Metab. 20: 1427, 1960.
Harakawa S., Yamashita S., Tobinaga T., Matsuo K., Hirayu H., Izumi M., Nagataki S., Melmed S. In vivo regulation of hepatic insulin-like growth factor-1 messenger ribonucleic acids with thyroid hormone. Endocrinol. Japon. 37: 205, 1990.
Wolf M., Ingbar S.H., Moses A.C. Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-I messenger ribonucleic acid and circulating levels in the rat. Endocrinology 725: 2905, 1989.
Scow R.O. Effect of growth hormone and thyroxine on growth and chemical composition of muscle, bone, and other tissues in thyroidectomized-hypophysectomized rats. Am. J. Physiol. 796: 854, 1959.
Thorngren K.G., Hansson L.I. Effect of thyroxine and growth hormone on longitudinal bone growth in the hypophysectomized rat. Acta Endocrinol. 74: 24, 1973.
Binoux M., Faivre-Bauman A., Lasarre C., Tixier Vidal A. Triiodothyronine stimulates the production of insulinlike growth factor-1 (IGF-1) by fetal hypothalamus cells cultured in serum-free medium. Devi. Brain. Res. 27: 319, 1985.
Ikeda T., Fujiama K., Takeuchi T., Honda M., Mokuda O., Tominaga M., Mashiba H. Effect of thyroid hormone on somatomedin-C release from perfused rat liver. Experientia 45: 170, 1989.
Schwander J.C., Hauri C., Zapf J., Froesch E.R. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 113: 297, 1983.
D’Ercole A.J., Stiles A.D., Underwood L.E. Tissue concentrations of somatomedin-C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. USA 87: 935, 1984.
Fagin J.A., Brown A., Melmed S. Regulation of pituitary insulin-like growth factor-I messenger RNA levels in rats harboring so-matomammotropic tumors: implications for growth hormone autoregulation. Endocrinology 722: 2204, 1988.
Fagin J.A., Fernandez-Mejia C., Melmed S. Pituitary insulin-like growth factor-l gene expression: regulation by triiodothyronine and growth hormone. Endocrinology 125: 2385, 1989.
Baumann G., Stolar M.W., Amburn K., Barsano C.P., DeVries B.C. A specific growth hormone-binding protein in human plasma: initial characterization. J. Clin. Endocrinol. Metab. 62: 134, 1986.
Leung D.W., Spencer S.A., Cachianes G. et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330: 537, 1987.
Baumann G., Amburn K.D., Buchanan T.A. The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone. J. Clin. Endocrinol. Metab. 64: 657, 1987.
Amit T., Hertz P., Ish-Shalom S., Lotan R., Luboshitzki R., Youdim M.B., Hochberg Z. Effects of hypo or hyper-thyroidism on growth hormone-binding protein. Clin. Endocrinol. 35: 159, 1991.
Baumann G., Amburn K., Shaw M.A. The circulating growth hormone-binding protein complex: a major constituent of plasma growth hormone in man. Endocrinology 722: 976, 1988.
Hochberg Z., Barkey R.J., Even L., Peleg I., Youdim M.B.H., Amit T. The effect of human growth hormone (GH) therapy on GH binding protein in GH deficient children. Acta Endocrinol. 725: 23, 1991.
Zapf J., Waldvogel M., Froesch E.R. Binding of nonsuppressible insulin-like activity in human serum. Evidence for a carrier protein. Arch. Biochem. Biophys. 768: 638, 1975.
Draznin B., Burstein P.J., Heinrich U.E., Johnson C.B., Emler C.A., Schalch D.S. Insulin-like growth factor and its carrier protein in hypopituitary and hypothyroid children and adults. Clin. Endocrinol. 72: 137, 1980.
Rosenfeld R.G., Lamson G., Pham H., Oh Y., Conover C., De Leon D.D., Donovan S.M., Ocrant I., Giudice L. Insulin-like growth factors binding proteins. Rec. Prog. Horm. Res. 46: 99, 1990.
Gillioz P., Giraud P., Conte-Devolx P., Jaquet P., Codaccioni J.L., Oliver C. Immunoreactive somatostatin in rat hypophyseal portal blood. Endocrinology 704: 1407, 1979.
Dupont A., Merand Y., Barden N. Effect of propylthiouracil and thyroxine on the inactivation of somatostatin by rat hypothalamus. Life Sci. 23: 2007, 1978.
Berelowitz M., Maeda K., Harris S., Frohman L.A. The effect of alterations in the pituitary-thyroid axis on hypothalamic content and in vitro release of somatostatin-like immunoreactivity. Endocrinology 707: 24, 1980.
Fernandez-Durango R., Arimura A., Fishback J., Schally A.V. Hypothalamic somatostatin and LH-RH after hy-pophysectomy, in hyper-or hypo-thyroidism, and during anesthesia in rats. Proc. Soc. Exp. Biol. Med. 157: 235, 1978.
Jones P.M., Burrin J.M., Ghatei M.A., O’Halloran J., Legon S., Bloom S.R. The influence of thyroid hormone status on the hy-pothalamo-hypophyseal growth hormone axis. Endocrinology 126: 1374, 1990.
Peterfreund R.A., Sawchenko P., Vale W. Thyroid hormones reversibly suppress somatostatin secretion and immunoreactivity in cultured neocortical cells. Brain Res. 328: 259, 1985.
De Los Frailes M.T., Cacicedo L., Lorenzo M.J., Fernandez G., Sanchez-Franco F. Thyroid hormone action on biosynthesis of somatostatin by fetal rat brain cells in culture. Endocrinology 123: 898, 1988.
Dieguez C., Foord S.M., Peters J.R., Hall R., Scanlon M.F. The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1–40) by dispersed rat anterior pituitary cells. Endocrinology 116: 1066, 1985.
Vale W., Vaughan J., Yamamoto G., Spiess J., Rivier J. Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. Endocrinology 112: 1553, 1983.
Downs T.R., Chomczynski P., Frohman L.A. Effects of thyroid hormone deficiency and replacement on rat hypothalamic growth hormone (GH)-re-leasing hormone gene expression in vivo are mediated by GH. Mol. Endocrinol. 4: 402, 1990.
Gershengorn M.C. Bihormonal regulation of the thyrotropin-releasing hormone receptor in mouse pituitary thyrotropic tumor cells in culture. J.Clin. Invest. 62: 937, 1978.
De Lèan A., Ferland L., Drouin J., Kelly P.A., Labrie F. Modulation of pituitary thyrotropin releasing hormone receptor levels by estrogens and thyroid hormones. Endocrinology 100: 1496, 1977.
Szabo M., Stachura M.E., Paleologos N., Bybee D.E., Frohman L.A. Thyrotropin-releasing hormone stimulates growth hormone release from the anterior pituitary of hypothyroid rats in vitro. Endocrinology 114: 1344, 1984.
Szabo M., Ruestow P.C., Kramer D.E. Growth hormone response to thyrotropin-releasing hormone in the urethane-anesthetized rat: effect of thyroid status. Endocrinology 117: 330, 1985.
Perrone M.H., Hinkle P.M. Regulation of pituitary receptors for thyrotropin-releasing hormone by thyroid hormones. J. Biol. Chem. 253: 5168, 1978.
Bigos S.T., Ridgway E.C., Kourides I.A., Maloof F. Spectrum of pituitary alterations with mild and severe thyroid impairment. J. Clin. Endocrinol. Metab. 46: 317, 1978.
Dieguez C., Page M.D., Scanlon M.F. Growth hormone neuroregulation and its alterations in disease states. Clin. Endocrinol. 28: 109, 1988.
Wartofsky L., Burman K.D. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr. Rev. 3: 164, 1982.
Valcavi R., Zini M., Portioli I. Triiodothyronine administration reduces serum growth hormone levels and growth hormone responses to thyrotropin-releasing hormone in patients with anorexia nervosa. Psychoneuroendocrinology 15: 287, 1990.
Harvey S. Tri-iodothyronine inhibition of thyrotropin-releasing hormone-induced growth hormone release from the chicken adenohypophysis in vitro. J. Endocrinol. 126: 75, 1990.
Lam K.S.L., Lechan R.M., Minamitani N., Segerson T.P., Reichlin S. Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism. Endocrinology 124: 1077, 1989.
Kato Y., Iwasaki Y., Iwasaki J., Abe H., Yanaihara N., Imura H. Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology 703: 554, 1978.
Chihara K., Kaji H., Minamitani N., Kodama H., Kita T., Goto B., Chiba T., Coy D., Fujita T. Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly. J. Clin. Endocrinol. Metab. 53: 81, 1984.
Bowers C.Y., Momany F.A., Reynolds G.A., Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114: 1537, 1984.
McCormick G.F., Millard W.J., Badger T.M., Bowers C.Y., Martin J.B. Dose-response characteristics of various peptides with growth hormone-releasing activity in the unanesthetized male rat. Endocrinology 177: 97, 1985.
Sartor O., Bowers C.Y., Chang D. Parallel studies of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 and human pancreatic growth hormone-releasing factor-44-NH2 in rat primary pituitary cell monolayer culture. Endocrinology 116: 952, 1985.
Massara F., Ghigo E., Demislis K., Tangolo D., Mazza E., Locatelli V., Müller E.E., Molinatti G.M., Camanni F. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects. Neuroendocrinology 43: 670, 1986.
Casanueva F.F., Villaneuva L., Cabranes J.A., Cabezas-Cerrato J., Fernandez-Cruz A. Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine and physical exercise in man. J. Clin. Endocrinol. Metab. 59: 526, 1984.
Massara F., Ghigo E., Goffi S., Molinatti G.M., Müller E.E., Camanni F. Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. J. Clin. Endocrinol. Metab. 59: 1025, 1984.
Valcavi R., Dieguez C., Zini M., Page M.D., Dotti C., Portioli I., Scanlon M.F. Effect of pyridostigmine and pirenzepine on GH responses to GHRH in hyperthyroid patients. Clin. Endocrinol. 35: 141, 1991.
Atterwill C.K., Atkinson D.J., Bermudez I., Balazs R. Effect of thyroid hormone and serum on the development of Na+, K+-adenosine triphosphatase and associated ion fluxes in cultures from rat brain. Neurosci. 74: 361, 1985.
Landa M.E., Gonzales Burgos G., Cardinali D.P. In vitro effect of thyroxine on cholinergic neurotransmission in rat sympathetic superior cervical ganglion. Neuroendocrinology 54: 552, 1991.
Melmed S., Yamashita S. Insulin-like growth factor-l action on hypothyroid rat pituitary cells: suppression of triiodothyronine-in-duced growth hormone secretion and messenger ribonucleic acid levels. Endocrinology 118: 1483, 1986.
Iranmanesh A., Lizarralde G., Johnson M.L., Veldhuis J.D. Nature of altered growth hormone secretion in hyperthyroidism. J. Clin. Endocrinol. Metab. 72: 108, 1991.
Chihara K., Kodama H., Kaji H., Kita T., Kashio Y., Okimura Y., Abe H., Fujita T. Augmentation by propranolol of growth hormone-releasing hormone-(1–44)-NH2-induced growth hormone release in normal short and normal children. J. Clin. Endocrinol. Metab. 61: 229, 1985.
Blackard W.G., Heidingsfelder S.A. Adrenergic receptor control mechanism for growth hormone secretion. J.Clin. Invest. 47: 1407, 1968.
Yeung R.T.T. Effect of propranonol on plasma growth hormone response in insulin-induced hypoglycaemia in thyrotoxic patients. J. Clin. Endocrinol. Metab. 37: 968, 1973.
Nillson O.R., Anderberg B., Karlberg B.E., Kagedal B. Cortisol, growth hormone and prolactin responses to insulin-induced hypoglycaemia in hyperthyroid patients before and during ß-adrenoceptor blockade. Clin. Endocrinol. 72: 581, 1980.
Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L., Hintz R.L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212: 1279, 1981.
Brazeau P., Guillemin R., Ling N., van Wyk J.J., Humbel R. Somatomedin inhibition of the growth hormone secretion stimulated by hypothalamic factor soma-tocrinin or the synthetic peptide hpGRF. C.R. Seances Acad. Sci. (III) 295: 651, 1982.
Goodyer C.G., De Stephano L., Guyda H.J. Effects of insulin-like growth factors on adult male rat pituitary function in tissue culture. Endocrinology 775: 1568, 1984.
Matsuo K., Yamashita S., Niwa M., Kurihara M., Harakawa S., Izumi M., Nagataki S., Melmed S. Thyroid hormone regulates rat pituitary insulin-like growth factor-I receptors. Endocrinology 726: 550, 1990.
Valcavi R., Zini M., Casoli P., Dotti C., Portioli I. Growth hormone responses to GHRH 1.44 and plasma somatomedin-C levels in patients with thyrotoxicosis. J. Endocrinol. Invest. 70(Suppl. 1): 13, 1987.
Abe H., Molitch M.E., van Wyk J.J., Underwood L.E. Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology 773: 1319, 1983.
Tannenbaum G.S., Guyda H.J., Posner B.I. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science 220: 77, 1983.
Vinik A., Pimstone B., Buchanan-Lee B. Impairment of hyper-glycemic induced growth hor-mone suppression in hyperthyroidism. J.Clin. Endocr. 11: 1534, 1968.
Ortigosa J.L., Mendoza F., Argote R.M., Garcia G., Cervantes C., Parra A. Propranolol effect on plasma glucose, free fatty acid, insulin and growth hormone in Graves’ disease. Metabolism 11: 1201, 1976.
Davies R.R., Turner S., Johnston D.G. Oral glucose inhibits growth hormone secretion in-duced by human pancreatic growth hormone releasing factor 1–44 in normal man. Clin. Endocrinol. 21: 477, 1984.
Masuda A., Shibasaki T., Nakahara M., Imaki T., Kiyisawa T., Jibiki K., Demura H., Shizume K., Ling N. The effect of glucose on growth hormone (GH)-re-leasing hormone-mediated GH secretion in man. J. Clin. Endocrinol. Metab. 60: 523, 1985.
Page M.D., Dieguez C., Valcavi R., Edwards C., Hall R., Scanlon M.F. Growth hormone (GH) responses to arginine and L-Dopa alone and after GHRH pretreatment. Clin. Endocrinol. 28: 551, 1988.
Alba-Roth J., Muller O.A., Schopohl J., von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.
Katz H.P., Youlton R., Kaplan S.L., Grumbach M.M. Growth and growth hormone. III. Growth hormone release in children with primary hypothyroidism and thyrotoxicosis. J. Clin. Endocr. 29: 346, 1969.
Cavagnini F., Peracchi M. Effect of reserpine on growth hormone response to insulin hypoglycaemia and to arginine infusion in normal subjects and hyperthyroid patients. J. Endocr. 51: 651, 1971.
Krulich L., McCann S.M. Influence of growth hormone (GH) on content of GH in the pituitary of normal rats. Proc. Soc. Exp. Biol. Med. 121: 1114, 1966.
Tannenbaum G.S. Evidence for autoregulation of growth hormone secretion via the central nervous system. Endocrinology 707: 2117, 1980.
Yamashita S., Slanina S., Kado H., Melmed S. Autoregulation of pituitary growth hormone messenger RNA levels in rats bearing transplantable mammosomatotrophic pituitary tumors. Endocrinology 118: 915, 1986.
Katz S.H., Molitch M., McCann S.M. Effects of hypothalamic implants of growth hormone (GH) on anterior pituitary weight and GH concentration. Endocrinology 85: 725, 1969.
Sheppard M.C., Kronheim S., Pimstone B.L. Stimulation by growth hormone of somatostatin re-lease from the rat hypothalamus in vitro. Clin. Endocrinol. 9: 583, 1978.
Conway S., McCann S.M., Krulich L. On the mechanism of growth hormone autofeedback regulation: possible role of somatostatin and growth hormone-releasing factor. Endocrinology 117: 2284, 1985.
Ross R.J.M., Borges F., Grossman A., Smith A., Ngahjoong L., Rees L.H., Savage M.O., Besser G.M. Growth hormone pretreatment in man blocks the response to growth hormone-releasing hormone: evidence for a direct effect of growth hormone. Clin. Endocrinol. 20: 117, 1987.
Saxena K.M., Crawford J.D., Talbot N.B. Childhood thyrotoxicosis: a long-term perspective. Br. Med. J. 2: 1153, 1964.
Hall R. Advances in the treatment of endocrine disorders. Practitioner 203: 494, 1969.
Root A.W., Rosenfeld R.L., Bongiovanni A.M., Eberlein W.R. The plasma growth hormone response to insulin-induced hypoglycaemia in children with retardation of growth. Pediatrics 39: 844, 1967.
McGillvray M.H., Aceto T. Jr., Frohman L.A. Plasma growth hormone responses and growth retardation of hypothyroidism. Am. J. Dis. Children 115: 273, 1968.
Chernausek S.D., Turner R. Attenuation of spontaneous, nocturnal growth hormone secretion in children with hypothyroidism and its correlation with plasma insulin-like growth factor I concentrations. J. Pediatr. 114: 968, 1989.
Buchanan C.R., Stanhope R., Adlard P., Jones J., Grant D.B., Preece M.A. Gonadotrophin, growth hormone and prolactin secretion in children with primary hypothyroidism. Clin. Endocrinol. 29: 427, 1988.
Iwatsubo H., Omori K., Okado Y., Fukuchi M., Miyai K., Abe H., Kumahara Y. Human growth hormone secretion in primary hypothyroidism before and after treatment. J. Clin. Endocr. 27: 1751, 1967.
Brauman H., Smets P., Corvilain J. Comparative study of growth hormone response to hypoglycaemia in normal subjects and in patients with primary myxedema or hyperthyroidism before and after treatment. J. Clin. Endocrinol. Metab. 36: 1162, 1973.
Williams T., Maxon H., Thorner M.O., Frohman L.A. Blunted growth hormone (GH) response to GH-re-leasing hormone in hypothyroidism resolves in the euthyroid state. J. Clin. Endocrinol. Metab. 61: 454, 1985.
Valcavi R., Jordan V., Dieguez C., John R., Manicardi E., Portioli I., Rodriguez-Arnao M.D., Gomez-Pan A., Hall R., Scanlon M.F. Growth hormone responses to GRF 1–29 in patients with primary hypothyroidism before and during replacement therapy with thyroxine. Clin. Endocrinol. 24: 693, 1986.
Hall K., Takano K., Enberg G., Fryklund L. Studies on the regulation of somatomedins A and B. In: Pecile A. & Müller E.E. (eds). Growth hormone and related peptides. Excerpta Med., Amsterdam, Oxford, p. 178, 1976.
D’Ercole A.J., Underwood L.E., van Wyk J.J. Serum somatomedin-C in hypopituitarism and in oth-er disorders of growth. J. Pediatr. 90: 375, 1977.
Furlanetto R.W., Underwood L.E., van Wyk J.J., D’Ercole A.J. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J.Clin. Invest. 60: 648, 1977.
Marek J., Schüllerovà M., Schreiberovà O., Lìma-novà Z. Effect of thyroid function on serum somatomedin activity. Acta Endocrinol. 96: 491, 1981.
Baxter R.C., Brown A.S., Turtle J.R. Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hor-mone disorders, hypothyroidism, and renal failure. Clin. Chem. 28: 488, 1982.
Chemausek S.D., Underwood L.E., Utiger R.D., van Wyk J.J. Growth hormone secretion and plasma somatomedin-C in primary hypothyroidism. Clin. Endocrinol. 79: 337, 1983.
Cavaliere H., Knobel M., Medeiros-Neto G. Effect of thyroid hormone therapy on plasma insulinlike growth factor I levels in normal subjects, hypothyroid patients and endemic cretins. Hormone Res. 25: 132, 1987.
Valcavi R., Dieguez C., Preece M., Taylor A., Portioli I., Scanlon M.F. Effect of thyroxine replacement therapy on plasma insulin-like growth factor 1 levels and growth hormone responses to growth hormone releasing factor in hypothyroid patients. Clin. Endocrinol. 27: 85, 1987.
Westermark K., Aim J., Skottner A., Karlsson A. Growth factors and the thyroid: effects of treatment for hyper- and hypothyroidism on serum IGF-I and urinary epidermal growth factor concentrations. Acta Endocrinol. 776: 415, 1988.
Bercu B.B., Diamond F.B. Jr. Growth hormone neurosecretory dysfunction. Clin. Endocrinol. Metab. 75: 537, 1986.
Burgess J.A., Smith B.R., Merimee T.J. Growth hormone in thyrotoxicosis: effect of insulin-induced hypoglycaemia. J.Clin. Endocr. 26: 1257, 1966.
Rosenfeld P.S., Wool M.S., Danforth E. Jr. Growth hormone response to insulin-induced hypoglycaemia in thyrotoxicosis. J.Clin. Endocr. 29: 777, 1969.
Finkelstein J.W., Boyar R.M., Hellman L. Growth hormone secretion in hyperthyroidism. J. Clin. Endocrinol. Metab. 36: 634, 1974.
Sasaki N., Tsuyusaki T., Nakamura H., Sanayama K., Niimi H., Nakajima H. Sleep-related growth hormone release in thyrotoxic patients before and during propylthiouracil therapy. Endocrinol. Japon. 32: 39, 1985.
Kühn E.R., Verheyen G., Chiasson R.B., Huts C., Huybrechts L., Van den Steen P., Decuypere E. Growth hormone stimulates the peripheral conversion of thyroxine into triiodothyronine by increasing the liver 5′-monodeiodinase activity in the fasted and normal fed chicken. Horm. Metab. Res. 79: 304, 1987.
Kühn E.R., Vanderpooten A., Huybrecths L.M., Decuypere E., Darras V., Sharp P.J. Hypothalamic hormones that release growth hormone stimulate hepatic 5′-monodeiodination activity in the chick embryo. J. Endocrinol. 118: 233, 1988.
Harvey S. Thyroid hormones inhibit growth hormone secretion in domestic fowl (Gallus Domesticus). J. Endocrinol. 96: 329, 1983.
Scanes C.G., Denver R.J., Bowen S. Effect of thyroid hormones on growth hormone secretion in broiler chickens. Poultry Science 65: 384, 1986.
Scanes C.G., Harvey S. Triiodothyronine (T3) inhibition of thyrotropin-releas-ing hormone (TRH) and growth hormone-releasing factor (GRF)-induced secretion of chicken growth hormone (GH) in vivo. Gen. Comp. Endocrinol. 73: 477, 1989.
Bray G.A. Calorigenic effect of human growth hormone in obesity. J.Clin. Endocr. 29: 119, 1969.
Root A.W., Bongiovanni A.M., Eberlein W.R. Inhibition of thyroidal radioiodine uptake by human growth hormone. J. Pediatr. 76: 422, 1970.
Lippe B.M., Van Herle A.J., LaFranchi S.H., Uller R.P., Lavin H., Kaplan S.A. Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone. J. Clin. Endocrinol. Metab. 40: 612, 1975.
Porter B.A., Refetoff S., Rosenfeld R.L., De Groot L.J., Fang V.S., Stark V. Abnormal thyroxine metabolism in hyposoma-totrophic dwarfism and inhibition of responsiveness to TRH during GH therapy. Pediatrics 37: 668, 1973.
Root A.W., Snyder P.J., Rezvani I., DiGeorge A.M., Utiger R.D. Inhibition of thyrotropin-releasing hormone-mediated secretion of thyrotropin by human growth hormone. J. Clin. Endocrinol. Metab. 36: 103, 1973.
Nakamoto J.M., Gertner J.M., Press C.M., Hintz R.L., Rosenfeld R.G., Genel M. Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH. J. Clin. Endocrinol. Metab. 62: 822, 1986.
Rosenthal S.M., Hulse J.A., Kaplan S.L., Grumbach M.M. Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men. J.Clin. Invest. 77: 176, 1986.
Hall R., Besser G.M., Schally A.V. etal. Actions of growth hormone-release inhibiting hormone in healthy men and acromegaly. Lancet ii: 581, 1973.
Siler T.M., Yen S.S.C., Vale W., Guillemin R. Inhibition by somatostatin of the release of TSH in-duced in man by thyrotropin-releasing factor. J. Clin. Endocrinol. Metab. 38: 742, 1974.
Carr D., Gòmez-Pan A., Weightman D.R., Roy V.C., Hall R., Besser G.M., Thorner M.O., McNeilly A.S., Serially A.V., Kastin A.J., Coy D.H. Growth hormone-release inhibiting hormone: actions on thyrotropin and prolactin secretion after thyrotropin-releasing hormone. Br. Med. J. 3: 67, 1975.
Williams T.C., Kelijman M., Crelin W.C., Downs T.R., Frohman L.A. Differential effects of somatostatin (SRIH) and a SRIH analog, SMS 201–995, on the secretion of growth hormone and thyroid-stimulating hormone in man. J. Clin. Endocrinol. Metab. 66: 39, 1988.
Grunfeld C., Sherman B.M., Cavalieri R.R. The acute effects of human growth hormone ad-ministration on thyroid function in normal men. J. Clin. Endocrinol. Metab. 67: 1111, 1988.
Jorgensen J.O.L., Pedersen S.A., Laurberg P., Weeke J., Skakkebaek N.E., Christiansen J.S. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J. Clin. Endocrinol. Metab. 69: 1127, 1989.
Azzarito C., Zini M., Dotti C., Valcavi R., Portioli I. Biosynthetic growth hormone does not alter the pituitary-thyroid function in “short normal” children. J. Endocrinol. Invest. 11 (suppl 2): 94, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Valcavi, R., Zini, M. & Portioli, I. Thyroid hormones and growth hormone secretion. J Endocrinol Invest 15, 313–330 (1992). https://doi.org/10.1007/BF03348744
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348744